Omeros reported $-50446000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Acelrx Pharmaceuticals ACRX:US USD -6208000 2M
Aerie Pharmaceuticals AERI:US USD -25022000 8.43M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
Cytokinetics CYTK:US USD -107033000 97.57M
Gilead Sciences GILD:US USD 3.28B 731M
Insmed INSM:US USD -119864000 21.78M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Knight Therapeutics Inc GUD:CN CAD 5.33M 10.78M
Macrogenics MGNX:US USD -22111000 16.82M
Mirati Therapeutics MRTX:US USD -185727000 9.22M
Omeros OMER:US USD -50446000 13.2M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Pfizer PFE:US USD 10.52B 2.78B
Regulus Therapeutics RGLS:US USD -7531000 387K
Sangamo Biosciences SGMO:US USD -51845000 8.99M
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
United Therapeutics UTHR:US USD 327.2M 112.7M
Vertex Pharmaceuticals VRTX:US USD 1.16B 6.8M
Vital Therapies VTL:US USD -20099000 491K
Xoma XOMA:US USD -4368000 398K